Doctor of Philosophy (PhD) in Pharmaceutical Sciences - Pharmaceutical Outcomes and Policy Track PHD Programme By University of Kentucky |TopUniversities

Doctor of Philosophy (PhD) in Pharmaceutical Sciences - Pharmaceutical Outcomes and Policy Track

Subject Ranking

# 201-250QS Subject Rankings

Main Subject Area

Pharmacy and PharmacologyMain Subject Area

Programme overview

Main Subject

Pharmacy and Pharmacology

Degree

MDiv

Study Level

PHD

The UK College of Pharmacy provides PhD candidates the opportunity to train alongside some of the most talented pharmaceutical scientists on the planet. Students get to do so in the world's largest College of Pharmacy facility, thanks to our open and inviting laboratories. The results; a bold and innovative training opportunity. Health care delivery faces the multiple challenges of limited resources, increasing expenditures, increasing expectations, greater complexity, costly new technology, and limited health care access. The need for professionally trained translational pharmaceutical research scientists in analyzing medication outcomes and policy planning has never been greater, as pharmaceutical policy issues become larger and more complex. Our society is accustomed to extensive drug use. In 2001, US physicians prescribed nearly 3 billion prescriptions costing in excess of $150 billion. In 2005, global drug expenditures surpassed $600 billion. But the cost is not just in dollars. In 1997, researchers projected that up to 140,000 deaths are caused annually in the U.S. by adverse events due to legally prescribed medications. Published estimates for the rate of hospital admissions due to adverse drug reactions range from 3-28%, and as many as 30% of all hospitalized patients experience an adverse drug event during their hospital stay. Nearly half of these adverse drug events are potentially preventable; thus, there is an urgent national imperative for rational and improved medication use. The POP program's training will focus on the relationship between pharmacotherapy and health outcomes, pharmacoeconomics, pharmacoepidemiology, informatics, and pharmaceutical policy. The program will prepare students for careers in the pharmaceutical industry, governmental positions related to pharmaceuticals, and academic positions focused on research related to pharmaceutical outcomes and policy. The program core is composed of courses in economics, epidemiology, policy, and econometrics. Prospective graduate students come from a national pool of applicants with backgrounds in pharmacy as well as other fields such as anthropology, biology, business administration, dentistry, economics, epidemiology, gerontology, health administration, medicine, nursing, public health, political science, psychology, public administration, public policy, social work, sociology and other majors. Most entry level students have a professional degree in pharmacy or a related graduate degree with a background or interest in pharmaceutical research.

Programme overview

Main Subject

Pharmacy and Pharmacology

Degree

MDiv

Study Level

PHD

The UK College of Pharmacy provides PhD candidates the opportunity to train alongside some of the most talented pharmaceutical scientists on the planet. Students get to do so in the world's largest College of Pharmacy facility, thanks to our open and inviting laboratories. The results; a bold and innovative training opportunity. Health care delivery faces the multiple challenges of limited resources, increasing expenditures, increasing expectations, greater complexity, costly new technology, and limited health care access. The need for professionally trained translational pharmaceutical research scientists in analyzing medication outcomes and policy planning has never been greater, as pharmaceutical policy issues become larger and more complex. Our society is accustomed to extensive drug use. In 2001, US physicians prescribed nearly 3 billion prescriptions costing in excess of $150 billion. In 2005, global drug expenditures surpassed $600 billion. But the cost is not just in dollars. In 1997, researchers projected that up to 140,000 deaths are caused annually in the U.S. by adverse events due to legally prescribed medications. Published estimates for the rate of hospital admissions due to adverse drug reactions range from 3-28%, and as many as 30% of all hospitalized patients experience an adverse drug event during their hospital stay. Nearly half of these adverse drug events are potentially preventable; thus, there is an urgent national imperative for rational and improved medication use. The POP program's training will focus on the relationship between pharmacotherapy and health outcomes, pharmacoeconomics, pharmacoepidemiology, informatics, and pharmaceutical policy. The program will prepare students for careers in the pharmaceutical industry, governmental positions related to pharmaceuticals, and academic positions focused on research related to pharmaceutical outcomes and policy. The program core is composed of courses in economics, epidemiology, policy, and econometrics. Prospective graduate students come from a national pool of applicants with backgrounds in pharmacy as well as other fields such as anthropology, biology, business administration, dentistry, economics, epidemiology, gerontology, health administration, medicine, nursing, public health, political science, psychology, public administration, public policy, social work, sociology and other majors. Most entry level students have a professional degree in pharmacy or a related graduate degree with a background or interest in pharmaceutical research.

Admission Requirements

6+

Scholarships

Selecting the right scholarship can be a daunting process. With countless options available, students often find themselves overwhelmed and confused. The decision can be especially stressful for those facing financial constraints or pursuing specific academic or career goals.

To help students navigate this challenging process, we recommend the following articles:

More programmes from the university

MD/PhD Program arrows

Go to Programme ::type_cta_button::
PHD Programmes 316